亚斯科伯酸盐治疗毒症重症患者的器官功能障碍:第2b期ASTER试验

D Clark Files¹, Michael A Matthay¹, Lorraine B Ware¹+29

• ¹Wake Forest University School of Medicine (D. C. F., K. W. G., and C. M.), Winston-Salem, NC; the University of California, San Francisco (M. A. M. and S. F.), San Francisco, the University of California, Los Angeles (S. Y. C., G. W. H., and K. D. L.), Los Angeles, CA; the Vanderbilt University Medical Center (L. B. W. and W. H. S.), Nashville, TN; the Johns Hopkins Hospital (R. G. B.), Baltimore, MD; the University of Colorado (N. R. A. and A. G.), the Denver Health Medical Center (I. S. D.), Denver, CO; Intermountain Health (S. M. B.), the University of Utah (E. S. H.), Salt Lake City, UT; the Cleveland Clinic (A. D.), Cleveland, the University of Cincinnati (R. D. H.), Cincinnati, OH; the Massachusetts General Hospital (A. S. F., K. H., W. H., P. L., and B. T. T.), Boston; the Baystate Medical Center (M. A. T.), Springfield, MA; the Medical University of South Carolina (A. G.), Charleston, SC; the Oregon Health and Science University (C. L. H. and A. K.), the Maine Medical Center (R. R.), Portland, OR; the Mount Sinai Hospital (A. M.), New York, NY; the Harborview Medical Center (B. R. H. R.), University of Washington, Seattle, WA, the University of Pittsburgh Medical Center (D. M. Y.), Pittsburgh, PA; and the Virginia Commonwealth University (A. A. F.), Richmond, VA.